A big dream. An even bigger frontier where anything is possible.



To learn more about Bellerophon, please go to www.bellerophon.com.


  1. Bryan NS, Bian K, Murad F. Discovery of the nitric oxide signaling pathway and targets for drug development. Front Biosci. 2009;14:1-18.
  2. Ng CKF, Chan MHM, Tai MHL, Lam CWK. Hepatorenal syndrome. Clin Biochem Rev. 2007;28(1):11-17.
  3. Landa N, Miller L, Feinberg MS, et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 2008;117(11):1388-1396.


INOMAX and INOtherapy are registered trademarks of INO Therapeutics LLC.

Bioabsorbable Cardiac Matrix—Licensed from BioLineRx (BL-1040).